Caterina Veroni Selected Research

Lysophosphatidylcholines (Lysophosphatidylcholine)

1/2020

Connecting Immune Cell Infiltration to the Multitasking Microglia Response and TNF Receptor 2 Induction in the Multiple Sclerosis Brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caterina Veroni Research Topics

Disease

10	Multiple Sclerosis 04/2024 - 07/2010
3	Demyelinating Diseases (Demyelinating Disease) 04/2024 - 12/2019
3	Epstein-Barr Virus Infections 01/2018 - 07/2010
2	Inflammation (Inflammations) 10/2022 - 01/2020
2	Megalencephalic leukoencephalopathy with subcortical cysts 12/2019 - 04/2016
1	Neuroblastoma 04/2024
1	Tuberous Sclerosis (Bourneville's Disease) 11/2023
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2023
1	Ischemic Stroke 10/2023
1	Alzheimer Disease (Alzheimer's Disease) 10/2022
1	Cognitive Dysfunction 10/2022
1	Atrophy 10/2022
1	Celiac Disease (Celiac Sprue) 10/2022
1	Disease Progression 01/2020
1	Gliosis 12/2019
1	Immune Reconstitution Inflammatory Syndrome 01/2018
1	Cysts 04/2016
1	Megalencephaly 04/2016
1	Brain Edema (Cerebral Edema) 04/2016
1	Astrocytoma (Pilocytic Astrocytoma) 04/2016
1	Autoimmune Diseases (Autoimmune Disease) 04/2016
1	Infections 01/2015

Drug/Important Bio-Agent (IBA)

3	EdaravoneIBA 04/2024 - 01/2020
3	RNA (Ribonucleic Acid)IBA 04/2024 - 07/2015
3	Proteins (Proteins, Gene)FDA Link 10/2022 - 04/2016
3	CytokinesIBA 01/2020 - 01/2015
2	AntioxidantsIBA 10/2023 - 01/2020
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 04/2024
1	Biomarkers (Surrogate Marker)IBA 11/2023
1	trans-sodium crocetinate (crocetin)IBA 11/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2022
1	Amyloid (Amyloid Fibrils)IBA 10/2022
1	Circular RNAIBA 10/2022
1	Nerve Growth Factor (NGF)IBA 10/2022
1	Antiviral Agents (Antivirals)IBA 10/2022
1	Glutens (Glutelin)IBA 10/2022
1	AntigensIBA 10/2022
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2020
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2020
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2019
1	LipidsIBA 01/2018
1	Natalizumab (Tysabri)FDA Link 01/2018
1	CalciumIBA 04/2016
1	Potassium Channels (Potassium Channel)IBA 04/2016
1	ErbB Receptors (EGF Receptor)IBA 04/2016
1	Epidermal Growth Factor (EGF)IBA 04/2016
1	Complementary DNA (cDNA)IBA 07/2015
1	ChemokinesIBA 01/2015
1	AntibodiesIBA 07/2010
1	B-Cell Activating FactorIBA 07/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2010

Therapy/Procedure

2	Therapeutics 04/2024 - 04/2016
1	Lasers (Laser) 01/2018